Dr Braham Shroot joins Signum Biosciences
This article was originally published in Scrip
Executive Summary
The private US biotechnology company Signum Biosciences has appointed Dr Braham Shroot, formerly chief scientific officer of Barrier Therapeutics, as CEO. Dr Shroot succeeds Dr Gregory Stock, who will continue with the company as a member of the board.